Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.8M Sell
123,256
-4,486
-4% -$243K 0.08% 182
2025
Q4
$6.26M Buy
127,742
+200
+0.2% +$9.33K 0.08% 188
2025
Q3
$5.5M Sell
127,542
-6,317
-5% -$247K 0.07% 201
2025
Q2
$5.14M Buy
+133,859
New +$5.11M 0.07% 205

Other funds holding GSK

Midwest Trust's GSK Position: Q1 2026 in Review

Midwest Trust reduced its GSK (GSK) stake by 3.5% in Q1 2026, selling an estimated $243K and leaving 123,256 shares worth $6.8M. The position accounts for 0.08% of the portfolio, ranked #182.

Midwest Trust first reported a position in GSK in Q2 2025 and has held it in 4 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Midwest Trust held 123,256 shares of GSK worth $6.8M as of Q1 2026.
  • Midwest Trust sold 4,486 GSK shares in Q1 2026, an estimated $243K.
  • GSK made up 0.08% of Midwest Trust's portfolio in Q1 2026, its #182 holding.
  • Midwest Trust first reported a position in GSK in Q2 2025 and has held it in 4 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.